The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery of Patients After sUCBT
To assess the safety and efficacy of coenzyme I for injection in promoting hematopoietic recovery after single-unit unrelated cord blood transplantation in hematological malignancies.
Hematopoietic Recovery
DRUG: Coenzyme I for Injection
Adverse Event(AE), Number of treatment-related adverse events as assessed by CTCAE v5.0, From the date of initial treatment to 30 days after transplantation
Neutrophil engraftment time, The first day of absolute neutrophil count ≥ 0.5×10\^9/L for 3 consecutive days post transplantation., 42 days post transplantation|Cumulative incidence of neutrophil engraftment on day 16, Cumulative incidence of neutrophil engraftment on day 16 post transplantation., 16 days post transplantation|platelet engraftment time, The first day of platelet count ≥ 20×10\^9/L for 7 consecutive days without platelet transfusions for 7 consecutive days post transplantation., 180 days post transplantation|Cumulative incidence of platelet engraftment on day 60, Cumulative incidence of platelet engraftment on day 60 post transplantation., 60 days post transplantation|Cumulative incidence of primary graft failure on day 30, Cumulative incidence of primary graft failure on day 30 post transplantation., 30 days post transplantation|Cumulative incidence of grade II-IV and III-IV acute GVHD on day 100, Cumulative incidence of grade II-IV and III-IV acute GVHD on day 100 post transplantation., 100 days post transplantation|Cumulative incidence of transplant-related mortality on day 180, Cumulative incidence of transplant-related mortality on day 180 post transplantation., 180 days post transplantation|Cumulative incidence of relapse on day 180, Cumulative incidence of relapse on day 180 post transplantation., 180 days post transplantation|Probability of overall survival, Probability of overall survival on day 180 post transplantation., 180 days post transplantation|Probability of leukemia-free survival, Probability of leukemia-free survival on day 180 post transplantation., 180 days post transplantation|Probability of GVHD-free relapse-free survival, Probability of GVHD-free relapse-free survival on day 180 post transplantation., 180 days post transplantation
A single-center, open-label, dose-escalation study to assess the safety and efficacy of coenzyme I for injection in promoting hematopoietic recovery after single-unit unrelated cord blood transplantation in hematological malignancies.